These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20530474)

  • 1. Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria.
    Alakija Kazeem Salami ; Fadeyi A; Ogunmodede JA; Desalu O
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(3):191-5. PubMed ID: 20530474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of adherence to highly active antiretroviral therapy amongst people living with HIV/AIDS in a rural setting in south-south Nigeria.
    Oku AO; Owoaje ET; Oku OO; Monjok E
    Afr J Reprod Health; 2014 Mar; 18(1):133-43. PubMed ID: 24796178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria.
    Afolabi BA; Afolabi MO; Afolabi AA; Odewale MA; Olowookere SA
    Afr Health Sci; 2013 Dec; 13(4):920-6. PubMed ID: 24940313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
    Azmeraw D; Wasie B
    Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria.
    Oku AO; Owoaje ET; Ige OK; Oyo-Ita A
    BMC Infect Dis; 2013 Aug; 13():401. PubMed ID: 24229404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status disclosure among People Living with HIV/AIDS in Ilorin, Nigeria.
    Salami AK; Fadeyi A; Ogunmodede JA; Desalu OO
    West Afr J Med; 2011; 30(5):359-63. PubMed ID: 22752825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
    Ruanjahn G; Roberts D; Monterosso L
    AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to highly active antiretroviral therapy (HAAT) at a Federal Medical Centre.
    Shaahu VN; Lawoyin TO; Sangowawa AO
    Afr J Med Med Sci; 2008 Mar; 37(1):29-36. PubMed ID: 18756852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of stigma and discrimination experienced by people living with HIV and AIDS receiving care/treatment in University of Ilorin Teaching Hospital (UITH), Ilorin, Nigeria.
    Owolabi RS; Araoye MO; Osagbemi GK; Odeigah L; Ogundiran A; Hussain NA
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):121-7. PubMed ID: 21521807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Talam NC; Gatongi P; Rotich J; Kimaiyo S
    East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica.
    Harvey KM; Carrington D; Duncan J; Figueroa JP; Hirschorn L; Manning D; Jackson S
    West Indian Med J; 2008 Jun; 57(3):293-7. PubMed ID: 19583131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic.
    Olowookere SA; Fatiregun AA; Adewole IF
    J Infect Dev Ctries; 2012 Nov; 6(11):809-16. PubMed ID: 23277507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria.
    Olowookere SA; Fatiregun AA; Akinyemi JO; Bamgboye AE; Osagbemi GK
    J Infect Dev Ctries; 2008 Oct; 2(5):369-72. PubMed ID: 19745505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART.
    Guaraldi G; Murri R; Orlando G; Orlandi E; Sterrantino G; Borderi M; Grosso C; Cattelan AM; Nardini G; Beghetto B; Antinori A; Esposito R; Wu AW
    HIV Clin Trials; 2003; 4(2):99-106. PubMed ID: 12671777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
    Beyene KA; Gedif T; Gebre-Mariam T; Engidawork E
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1007-15. PubMed ID: 19650153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.